Bhavesh Ashar - 05 Jan 2023 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Chief Commercial Officer
Signature: /s/ Francis I. Perier, Jr. as Attorney-in Fact
Issuer symbol: SWTX
Transactions as of: 05 Jan 2023
Net transactions value: -$45,821
Form type: 4
Filing time: 09 Jan 2023, 16:00:14 UTC
Previous filing: 13 Oct 2022
Next filing: 05 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Award		+22,663	+94%		46,761	05 Jan 2023	Direct	F1
transaction	SWTX	Common Stock	Tax liability	$45,821	-1,665	-3.6%	$27.52	45,096	06 Jan 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWTX	Stock Option (Right to Buy)	Award	$0	+70,000		$0.000000	70,000	05 Jan 2023	Common Stock	70,000	$27.64	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on January 5, 2024, another thirty three percent (33%) to vest on January 5, 2025 and the remaining thirty four percent (34%) to vest on January 5, 2026, such that the restricted stock awards are fully vested on January 5, 2026.
F2	Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
F3	This option shall vest in 48 equal monthly installments subject to continued service to the Issuer by the Reporting Person.